SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following a launch failure where Blue Origins rocket placed the BlueBird 7 satellite into an unusable, off-nominal orbit, prompting investors to debate the company's reliance on launch partners versus its long-term commercial potential. While some in the community see the sharp sell-off as a strategic buying opportunity due to insurance coverage and intact fundamentals, others are expressing frustration over management's communication and the potential impact on future launch cadence.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility as investors clash over whether the recent price surge represents a legitimate breakout tied to global event expansion or a classic pump-and-dump scheme. The community is deeply divided, with some traders highlighting successful price action while others aggressively warn of manipulation, potential rug-pull risks, and the dangers of chasing hype in the memecoin space.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing massive volatility and high trading volume as investors chase speculative gains fueled by an executive order to fast-track psychedelic research. The community is sharply divided, with bulls betting on a short squeeze due to a limited float and potential government support, while bears warn of pump-and-dump mechanics, potential dilution, and a lack of direct clinical data connecting the stock to the reported ibogaine catalyst.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors rally around the company's confirmed acquisition of a majority stake in the Tanbreez rare earth project, a key milestone that materially de-risks the asset and fuels speculation regarding future government investment and supply chain significance. The community is actively discussing the stock's potential for a massive short squeeze, with many pointing to heavy volume and limited borrow availability as signals that the stock is poised for significant upside.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending following reports that it is in talks with Google to develop custom AI chips, including a memory processing unit and an inference-optimized TPU. The community is actively discussing how this potential partnership, aimed at optimizing AI efficiency, positions Marvell as a key infrastructure player in a market shifting its focus from training to inference workloads.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is currently a focal point for investors debating its transition from a pure-play Bitcoin miner to an AI infrastructure and power capacity operator. The community is actively tracking potential short squeeze dynamics, contrasting the stock's recent volatility and management criticism against bullish sentiment surrounding institutional accumulation and long-term infrastructure value.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as frustrated investors discuss the relentless rally in semiconductor stocks, which has driven this leveraged bear ETF to new lows. The community is actively debating whether the current market environment is a parabolic blow-off top driven by AI exuberance and geopolitical distractions, or if they should continue averaging down in anticipation of a sharp sector pullback.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is capturing significant market attention following a major executive order that prioritizes and fast-tracks the federal review and research of psychedelic-based treatments for mental health conditions. Investors and the community are actively debating the company's competitive advantage as a leader in Phase 3 psilocybin trials, with many closely monitoring potential regulatory tailwinds and the upcoming clinical data readouts.

Operates as a holding company with interest in providing social shopping platform solutions

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is experiencing intense volatility as retail traders push the stock through significant intraday swings, drawing heavy attention to its low-float status and high short interest. While bulls are banking on a potential short squeeze and upcoming earnings catalysts, the community remains deeply divided, with many debating whether the rapid price movements signal real growth or are merely a classic pump-and-dump cycle.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and aggressive trading volume as the market reacts to shifting Bitcoin momentum and internal capital strategies like its proposed dividend changes. Community members remain deeply divided, with bulls pointing to the company's aggressive Bitcoin accumulation as a long-term supply squeeze, while bears argue the stock is overextended and tied to unsustainable debt and dilution cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells $312,950.00 in Stock

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) CEO Richard Nolan Townsend sold 55,000 shares of the company's stock in a transaction on Monday, April 6th. The stock was sold at an average...

Insider Selling: Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells 55,000 Shares of Stock

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) CEO Richard Nolan Townsend sold 55,000 shares of the firm's stock in a transaction dated Monday, April 6th. The shares were sold at an average...

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) have received an average rating of "Moderate Buy" from the nine analysts that are presently covering the stock, MarketBeat.com...

Lexeo Therapeutics (NASDAQ:LXEO) Issues Quarterly Earnings Results

Lexeo Therapeutics (NASDAQ:LXEO - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.32) by $0.03...

Lexeo Therapeutics (LXEO) Projected to Post Earnings on Monday

Lexeo Therapeutics (NASDAQ:LXEO) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of "Moderate Buy" by Analysts

Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the ten brokerages that are currently covering the company, Marketbeat...

Lexeo Therapeutics (NASDAQ:LXEO) Shares Up 10.4% - What's Next?

Lexeo Therapeutics (NASDAQ:LXEO) Stock Price Up 10.4% - Time to Buy...

Lexeo Therapeutics Highlights FA and PKP2 Cardiac Gene Therapy Progress at Oppenheimer Conference

Lexeo Therapeutics (NASDAQ:LXEO) executives outlined the company's focus on precision medicines for inherited cardiac diseases during a presentation at Oppenheimer's 36th Annual Healthcare Life...

Lexeo Therapeutics (NASDAQ:LXEO) COO Jose Manuel Otero Sells 3,016 Shares

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) COO Jose Manuel Otero sold 3,016 shares of the business's stock in a transaction that occurred on Wednesday, February 18th. The stock was sold...

Jose Manuel Otero Sells 3,016 Shares of Lexeo Therapeutics (NASDAQ:LXEO) Stock

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) COO Jose Manuel Otero sold 3,016 shares of Lexeo Therapeutics stock in a transaction on Wednesday, February 18th. The shares were sold at an...

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.

Current Price	$6.91
Prev Close	$6.58
Open	$6.81
Dividend Yield	0.00%
50-Day Moving Average	$6.43
Beta	1.97
Avg. Volume	956,488.25
PE Ratio	-3.15

52-Week High	$10.99
52-Week Low	$2.43
Market Capitalization	$511.94M
EPS (Annual)	-$1.86
Price to Book	2.04
Revenue Per Employee	$0.00

LXEO
Lexeo Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LXEO News

LXEOLexeo Therapeutics Inc.